Public Company News

AP Memory launches brand-new product series of 512Mb Ultra-High-Speed (UHS) and 32Mb Ultra-Low-Swing (ULS) PSRAM

HSINCHU, June 6, 2022 /PRNewswire/ -- AP Memory, the global leading design company that provides customized memory solution, has announced today the launch of its new Ultra High Speed (UHS) and Ultra Low Swing (ULS) PSRAM. AP Memory rolls out AP351216C/AP351208, to further expand the density of A...

2022-06-06 20:00 3685

Canadian Solar Sells to SPIC Brasil 70% Stake in 738 MWp Solar Projects

GUELPH, ON, June 6, 2022 /PRNewswire/ -- Canadian Solar Inc.  ("Canadian Solar" or the "Company") (NASDAQ: CSIQ), today announced it signed an agreement with SPIC Brasil, a leading power generation company inBrazil, to sell 70% stake in the Company's 738 MWp solar ...

2022-06-06 19:00 2488

Futu Holdings Achieves Solid First-Quarter Growth Amid Market Volatility with 67.9% YoY Increase in Paying Clients

- Flagship trading apps moomoo and Futubull have acquired 18.1 million global users as of quarter end PALO ALTO, Calif., June 6, 2022 /PRNewswire/ -- Moomoo's parent company Futu Holdings Limited (Nasdaq: FUTU) (Futu), a leading tech-driven online brokerage and wealth management platform, r...

2022-06-06 18:00 4317

Tuya to Report First Quarter 2022 Financial Results on June 14, 2022 Eastern Time

SANTA CLARA, Calif., June 6, 2022  /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA), a global leading IoT cloud development platform, today announced that it will report its first quarter 2022 unaudited financial results after the market closes onTuesday, June 14, 2022. Tuya's ma...

2022-06-06 18:00 2221

Boqii Announces Fourth Quarter and Full Fiscal Year 2022 Unaudited Financial Results

Fourth Quarter Revenues of RMB249.9 million, up 8.4% year-over-year Full Year Revenues of RMB1,186.4 million, up 17.4 % year-over-year SHANGHAI, June 6, 2022 /PRNewswire/ -- Boqii Holding Limited ("Boqii" or the "Company") (NYSE: BQ), a leading pet-focused platform inChina, today announced its u...

2022-06-06 17:30 3737

Weibo Announces Results of 2022 Annual General Meeting

BEIJING, June 6, 2022 /PRNewswire/ -- Weibo Corporation ("Weibo" or the "Company") (NASDAQ: WB and HKEX: 9898), a leading social media inChina, today announced that the following proposed resolutions submitted for shareholder approval have been adopted at its 2022 annual general meeting of shareh...

2022-06-06 17:00 3566

"Captain Tsubasa: Dream Team" 5th Anniversary Kicks Off & New Players Wearing the JUVENTUS Official Kit Debut

TOKYO, June 6, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its head-to-head football simulation gameCaptain Tsubasa: Dream Teamkicked off its special 5th Anniversary with the JUVENTUS OFFICIAL CAMPAIGN: Gifts for All and more in-game campaigns onFriday, June 3....

2022-06-06 15:15 2926

CStone and Pfizer announce NMPA approval of sugemalimab in patients with unresectable stage III non-small cell lung cancer

* The National Medical Products Administration approved sugemalimab for the treatment of patients with unresectable stage III non-small cell lung cancer whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy * Sugemalimab became the first anti-PD-...

2022-06-06 12:23 3199

iQIYI Showcases Technology-Enabled Green Production Techniques on World Environment Day

BEIJING, June 6, 2022 /PRNewswire/ -- On Jun. 5, iQIYI, an innovative market-leading online entertainment service inChina, shared its commitment to a sustainable future on World Environment Day, a day where businesses, communities, and governments around the world come together to raise awareness...

2022-06-06 12:20 6665

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) combined with chemotherapy in advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster discussion featuring a phase II ...

2022-06-06 09:00 2390

Akeso announces oral presentation featuring promising clinical data of Cadonilimab (PD-1/CTLA-4 BsAbs, AK104) for the first-line treatment of R/M cervical cancer at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released updated results of Cadonilimab (PD-1/CTLA-4 Bispecific, AK...

2022-06-06 09:00 2271

Akeso releases promising data of Ivonescimab (PD-1/VEGF BsAbs, AK112) for advanced NSCLC at ASCO 2022

HONG KONG, June 5, 2022 /PRNewswire/ -- Akeso, Inc. (9926.HK) ( "Akeso" ), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, released clinical details in poster presentation featuring phase Ib...

2022-06-06 09:00 2464

Pepper Money's SOLANA Improves Business Volumes by 70% with the Appian Low-Code Platform

SYDNEY, June 6, 2022 /PRNewswire/ -- Appian (NASDAQ: APPN) announced today that Pepper Money, a leading consumer finance company inAustralia is using the  Appian Low-Code Platform to support its Asset Finance Loan Origination solution, SOLANA, which has allowed the company to grow its business vol...

2022-06-06 07:00 4347

Recon Receives NASDAQ Notification Regarding Minimum Bid Requirements

BEIJING, June 3, 2022 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that onJune 1, 2022, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in compliance with the minimum bid price requ...

2022-06-04 04:30 6984

Dogness (International) Corporation Closes $12 Million Offering

DONGGUAN, China, June 3, 2022 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced that it closed a previously announced offerin...

2022-06-04 01:48 8769

Dada Group's JDDJ fulfilled the first order in JD618 Grand Promotion, and saw sales surge

SHANGHAI, June 3, 2022 /PRNewswire/ -- On May 31, only 10 minutes after the official opening of JD618 Grand Promotion, one consumer who lives in Chaoyang District,Beijing, had received the milk powder and kid toys she bought from JDDJ. These products labeled with "Shop Now", are supported by Dada...

2022-06-03 23:45 7792

Gracell Biotechnologies Schedules Clinical Update Call After EHA2022

SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China, June. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today a...

2022-06-03 23:00 7013

ASIP Tech selected by Wizz Air for free inflight connectivity

NEW YORK, June 3, 2022 /PRNewswire/ -- AS-IP Tech (USOTC: IPTK) announced today it has signed an agreement with Wizz Air (LSE: WIZZ) to provide connectivity on its fleet of A320 and A321 UK based aircraft. In a world first, Wizz Air will integrate AS-IP Tech's fflya Bluetooth platform into its m...

2022-06-03 22:00 7046

JX Luxventure receives Nomination for the "Best Software Solution Provider" Award

HAIKOU, China, June 3, 2022 /PRNewswire/ -- JX Luxventure Limited (Nasdaq: LLL) (the "Company"), a company delivering comprehensive products solutions to global elite families serviced by our business customers with business segments covering menswear, cross-border merchandise and tourism, announ...

2022-06-03 21:36 9341

ProSomnus® to Present Data at SLEEP 2022, the Annual Meeting of the American Academy of Sleep Medicine and the Sleep Research Society

SAN FRANCISCO, June 3, 2022 /PRNewswire/ -- ProSomnus, a leader in patient-preferred medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the results of three studies evaluating its FDA-cleared Oral Appliance Therapy (OAT) devices in the treatment of OSA. ProSomnus ...

2022-06-03 20:00 7640
1 ... 599600601602603604605 ... 765